In recent weeks, Synthomer plc, headquartered in London, has been examining the possibility of raising tens of millions of pounds through a new share issuance. This initiative comes as the company grapples with a significant downturn in demand for its specialty chemicals, affecting its financial stability. Driven by a necessity to strengthen its debt-laden balance sheet, the company is collaborating with bankers from JP Morgan to evaluate this potential capital raise. Over the past year, Synthomer has experienced a alarming drop in its stock value, plummeting by more than 60%. The company's market capitalization currently stands at approximately £90 million, indicating serious financial challenges as it seeks to enhance its fiscal position. Sources close to the company suggest that if the share sale goes ahead, it may aim to raise an amount that surpasses its current market value, though there remains uncertainty about whether the deal will be executed as planned. Synthomer, known for producing specialty chemicals for various sectors including medical gloves, construction, coatings, and adhesives, has faced pressures not only from declining demand but also due to a substantial debt load. In an update provided last month, management indicated that the implementation of cost reduction measures, described as 'self-help' programs, had helped mitigate some of the effects stemming from weaker market conditions. This proactive approach demonstrates the company's commitment to navigate through a challenging economic landscape. In addition to exploring the share sale, Synthomer is also in talks with its lenders to negotiate revised terms regarding its existing debt obligations, which are set to mature in the latter half of 2027. The company aims to leverage any potential capital raise as part of a broader strategy to decrease its leverage ratio and secure a sustainable pathway for future operations. A successful equity raise would also bolster the company's efforts to stabilize its business model in the face of ongoing financial challenges.